Qube Research & Technologies (QRT)’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6M	Buy	2,249,583 +1,188,455	+112%	+$6.03M	0.02%	1246
2025 Q4	$4.52M	Buy	1,061,128 +938,628	+766%	+$3.57M	0.01%	1823
2025 Q3	$391K	Buy	+122,500	New	+$276K	﹤0.01%	2771
2025 Q2	–	Sell	-54,808	Closed	-$34.8K	–	3622
2025 Q1	$34.8K	Sell	54,808 -300	-0.5%	-$233	﹤0.01%	3168
2024 Q4	$56.8K	Hold	55,108	–	–	﹤0.01%	3083
2024 Q3	$65K	Buy	55,108 +500	+0.9%	+$635	﹤0.01%	2814
2024 Q2	$66.6K	Sell	54,608 -78,591	-59%	-$156K	﹤0.01%	2681
2024 Q1	$290K	Buy	133,199 +132,940	+51,328%	+$245K	﹤0.01%	2837
2023 Q4	$401	Hold	259	–	–	﹤0.01%	3932
2023 Q3	$334	Buy	+259	New	+$408	﹤0.01%	3710
2023 Q2	–	Sell	-13,050	Closed	-$19.7K	–	2489
2023 Q1	$19.7K	Sell	13,050 -43,231	-77%	-$97.7K	﹤0.01%	2313
2022 Q4	$90K	Buy	56,281 +5,695	+11%	+$8.43K	﹤0.01%	2028
2022 Q3	$73K	Sell	50,586 -5,260	-9%	-$8.1K	﹤0.01%	2058
2022 Q2	$102K	Buy	+55,846	New	+$107K	﹤0.01%	1945
2021 Q3	–	Sell	-18,101	Closed	-$115K	–	2301
2021 Q2	$115K	Buy	+18,101	New	+$141K	﹤0.01%	1923